Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.18 [1.06-1.32],0.00226193301076587,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NRP1,Neuropilin-1,Inverse variance weighted,12,0.82 [0.72-0.94],0.00342567683494966,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.91 [0.85-0.97],0.00469096662437171,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.52 [1.12-2.06],0.00708472198539024,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.86 [0.77-0.96],0.00734243397508079,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.75 [0.6-0.93],0.0075569732228191,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.86 [1.17-2.93],0.00815363415919405,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,0.77 [0.64-0.94],0.00872066446721744,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.06 [1.01-1.12],0.0106589360268136,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.86 [0.76-0.97],0.0133294198268375,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPON1,Spondin-1,Inverse variance weighted,21,0.86 [0.76-0.97],0.0134785478375513,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSD,Cathepsin D,Inverse variance weighted,17,1.19 [1.04-1.36],0.0136395570563287,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.65 [0.46-0.92],0.0147283557067853,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.91 [0.85-0.98],0.0169381050051035,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSO,Cathepsin O,Inverse variance weighted,6,0.77 [0.62-0.95],0.0174340461258537,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL15,Interleukin-15,Wald ratio,1,28.78 [1.78-464.25],0.0178716901615557,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.85 [0.74-0.97],0.0187254889997774,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSS,Cathepsin S,Inverse variance weighted,23,0.89 [0.8-0.98],0.0218469319218044,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.71 [0.54-0.95],0.0225444653396552,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.86 [0.76-0.98],0.0241876216860862,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.85 [0.74-0.98],0.027234748001159,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.3 [1.03-1.64],0.028321915912825,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.89 [0.8-0.99],0.0286107856933281,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.54 [0.31-0.94],0.0290935841268869,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.2 [1.02-1.41],0.030631429965498,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,1.12 [1.01-1.25],0.0341755021500304,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.19 [1.01-1.41],0.0356848911458385,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.07 [1-1.15],0.0375354315238679,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.14 [1.01-1.29],0.0401645056364663,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.88 [0.77-1],0.0416660345650697,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.83 [0.7-0.99],0.0421674580568028,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLIN3,Perilipin-3,Wald ratio,1,0.5 [0.26-0.98],0.0425602673705126,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,3.03 [1.03-8.96],0.0448297086033332,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,UMOD,Uromodulin,Inverse variance weighted,29,1.07 [1-1.14],0.0449376826667487,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD70,CD70 antigen,Inverse variance weighted,28,0.92 [0.85-1],0.0458251275364308,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.18 [1-1.38],0.0461961073004741,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,11,0.86 [0.75-1],0.0482639972161268,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1.08 [1-1.17],0.0493282498076638,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.87 [0.76-1],0.0526086489006459,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.92 [0.85-1],0.0530869383326725,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK4,Kallikrein-4,Inverse variance weighted,17,1.11 [1-1.23],0.0534736572509267,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.86 [0.74-1],0.0545989601380689,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.67 [0.44-1.01],0.0558496770948495,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SDC1,Syndecan-1,Inverse variance weighted,2,1.4 [0.99-1.99],0.0569549654049649,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LMNB2,Lamin-B2,Wald ratio,1,3.21 [0.96-10.71],0.0580554645391025,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.88 [0.78-1.01],0.0607468427976738,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.16 [0.99-1.36],0.0618214379171138,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH15,Cadherin-15,Inverse variance weighted,18,0.89 [0.79-1.01],0.0619220387834104,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH3,Cadherin-3,Inverse variance weighted,2,1.71 [0.97-3.02],0.06300502818647,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.06 [1-1.12],0.064738526412437,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CFD,Complement factor D,Inverse variance weighted,11,1.16 [0.99-1.35],0.0665548570203488,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.22 [0.99-1.51],0.067493908163243,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.71 [0.96-3.05],0.0681162265400013,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.85 [0.7-1.01],0.0702217791986249,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,THBD,Thrombomodulin,Inverse variance weighted,5,1.24 [0.98-1.57],0.0711381387135299,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.21 [0.98-1.49],0.0712345377201277,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ITGB2,Integrin beta-2,Inverse variance weighted,4,0.75 [0.54-1.03],0.0719678098086217,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.16 [0.99-1.36],0.0726395584372335,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.82 [0.65-1.02],0.0742143713019809,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.24 [0.98-1.58],0.0748960241697454,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CX3CL1,Fractalkine,Inverse variance weighted,9,1.28 [0.97-1.68],0.0754220820354854,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.69 [0.46-1.04],0.0760925829127245,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,1.04 [1-1.1],0.078275681686181,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MILR1,Allergin-1,Inverse variance weighted,33,0.95 [0.9-1.01],0.0795362927805622,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DSG2,Desmoglein-2,Inverse variance weighted,11,1.17 [0.98-1.41],0.0816839145082881,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.68 [0.94-3],0.0818978019515408,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.69 [0.45-1.05],0.0832643199363819,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.8 [0.92-3.51],0.0842098387111484,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.93 [0.85-1.01],0.0864454213152672,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.21 [0.97-1.49],0.0873986845427766,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,1.12 [0.98-1.28],0.0885937625332486,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.19 [0.97-1.47],0.0892708789149262,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.91 [0.82-1.02],0.0963192178036567,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.24 [0.96-1.59],0.0969234013391594,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRND,Prion-like protein doppel,Inverse variance weighted,9,1.11 [0.98-1.26],0.0970140333008269,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,0.85 [0.7-1.03],0.0975321508078102,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,2.92 [0.82-10.39],0.0984584956481541,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.93 [0.85-1.01],0.0996141489072124,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.74 [0.51-1.06],0.10292755344085,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.1 [0.98-1.23],0.103286217182283,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.66 [0.4-1.09],0.103369829736829,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.27 [0.95-1.71],0.107249855693252,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.86 [0.72-1.03],0.108219669543351,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.92 [0.83-1.02],0.108927707976223,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.75 [0.53-1.07],0.109361305841469,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.07 [0.98-1.17],0.11028686243547,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.06 [0.99-1.15],0.111471101467018,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TCN2,Transcobalamin-2,Inverse variance weighted,34,0.94 [0.87-1.01],0.11258833481674,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.91 [0.81-1.02],0.113401131919456,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,1.21 [0.95-1.52],0.116723411651009,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.3 [0.93-1.81],0.118569835444208,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.38 [0.11-1.29],0.119801933106901,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.21 [0.95-1.53],0.119990530526958,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.41 [0.91-2.17],0.120025047385673,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.94 [0.87-1.02],0.120853082493263,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.87 [0.72-1.04],0.126501540114479,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.87 [0.73-1.04],0.126755807176595,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.07 [0.98-1.17],0.127337270862212,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.8 [0.6-1.07],0.128491948635853,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRTN3,Myeloblastin,Inverse variance weighted,21,1.09 [0.98-1.22],0.130640090099257,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL16,Pro-interleukin-16,Inverse variance weighted,16,0.92 [0.82-1.03],0.132107883715406,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL17C,Interleukin-17C,Inverse variance weighted,3,1.44 [0.89-2.32],0.134956865673576,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.13 [0.96-1.32],0.136128280572056,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,0.57 [0.27-1.21],0.141463592359127,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.22 [0.94-1.58],0.141527708431074,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.07 [0.98-1.18],0.14607818436577,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.31 [0.91-1.88],0.146231645522119,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EDN1,Endothelin-1,Inverse variance weighted,3,0.85 [0.69-1.06],0.14625045731806,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.12 [0.96-1.3],0.14769571364889,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.09 [0.97-1.22],0.150689137890443,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,0.91 [0.8-1.03],0.151033127470727,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.92 [0.83-1.03],0.153065054098078,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.84 [0.67-1.07],0.155448230873345,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,1.23 [0.92-1.64],0.157447485819292,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.89 [0.75-1.05],0.160456523937187,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.19 [0.93-1.53],0.163790564961303,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,OCLN,Occludin,Inverse variance weighted,2,1.3 [0.9-1.88],0.168746979447643,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.89 [0.76-1.05],0.170333520637651,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD276,CD276 antigen,Inverse variance weighted,20,1.07 [0.97-1.17],0.170531349700081,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.08 [0.97-1.2],0.171455949994957,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.77 [0.53-1.12],0.174443733663411,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.83 [0.64-1.08],0.174738174444457,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.95 [0.87-1.02],0.17542402964029,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.73 [0.46-1.15],0.175815448136826,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PYY,Peptide YY,Inverse variance weighted,6,1.18 [0.93-1.5],0.180209264913724,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,1.17 [0.93-1.46],0.183039256770393,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,2.03 [0.72-5.75],0.18317705629844,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.32 [0.87-1.98],0.187886387866557,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.06 [0.97-1.17],0.18955912564732,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.52 [0.81-2.84],0.190202763473673,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.76 [0.5-1.15],0.192059763179879,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.88 [0.73-1.06],0.193576299855811,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.1 [0.95-1.28],0.195594439455638,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DSC2,Desmocollin-2,Inverse variance weighted,9,0.9 [0.76-1.06],0.196086161244239,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VWC2,Brorin,Inverse variance weighted,22,1.09 [0.96-1.23],0.198476855650445,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.88 [0.72-1.07],0.198526147609944,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.79 [0.55-1.13],0.199990423426401,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.1 [0.95-1.26],0.202672411810851,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CPA2,Carboxypeptidase A2,Inverse variance weighted,17,0.92 [0.82-1.04],0.203305392472691,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1.11 [0.94-1.31],0.20488302615747,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.06 [0.97-1.16],0.205865689417224,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FBLN2,Fibulin-2,Inverse variance weighted,11,0.92 [0.8-1.05],0.210152283396035,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.06 [0.97-1.15],0.211129695698776,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.92 [0.81-1.05],0.211694924613913,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.9 [0.77-1.06],0.21245426748422,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.54 [0.21-1.43],0.21457823947948,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.36 [0.84-2.21],0.214982794498621,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DLK1,Protein delta homolog 1,Inverse variance weighted,25,1.07 [0.96-1.19],0.21800353866453,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SERPINB8,Serpin B8,Inverse variance weighted,28,0.96 [0.9-1.02],0.218176352976,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.18 [0.91-1.54],0.219013418807816,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,0.93 [0.82-1.05],0.220114308129572,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NFASC,Neurofascin,Inverse variance weighted,15,0.93 [0.82-1.05],0.221210008183756,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.05 [0.97-1.15],0.226039099897802,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.94 [0.85-1.04],0.227095967751051,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCGB1A1,Uteroglobin,Inverse variance weighted,12,0.92 [0.8-1.06],0.228565274736118,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.79 [0.53-1.16],0.22957732960839,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL18,Interleukin-18,Inverse variance weighted,16,1.17 [0.91-1.5],0.232582388264961,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,1.08 [0.95-1.22],0.235953756880517,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.09 [0.94-1.26],0.237863921200804,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.21 [0.88-1.66],0.241207563286079,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PCDH1,Protocadherin-1,Wald ratio,1,0.7 [0.39-1.28],0.245584720885765,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.15 [0.91-1.46],0.249834077028514,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MMP10,Stromelysin-2,Inverse variance weighted,22,1.07 [0.95-1.21],0.250126063390091,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.03 [0.98-1.08],0.251198027956686,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.07 [0.95-1.21],0.253783251505745,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,0.95 [0.88-1.03],0.254851756848572,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.96 [0.9-1.03],0.258289621485844,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CALB2,Calretinin,Wald ratio,1,1.57 [0.71-3.47],0.260502316974915,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.95 [0.86-1.04],0.261896489345999,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.61 [0.7-3.74],0.265695046026673,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.04 [0.97-1.1],0.268227697999955,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.65 [0.3-1.4],0.26848485530278,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MSLN,Mesothelin,Inverse variance weighted,25,1.04 [0.97-1.13],0.268505230394145,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.67 [0.33-1.37],0.269177701265058,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,1.1 [0.93-1.29],0.272626862096122,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.51 [0.15-1.73],0.278967243392545,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.34 [0.79-2.26],0.279229206450001,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGMN,Legumain,Inverse variance weighted,12,1.08 [0.94-1.25],0.282058519348623,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD46,Membrane cofactor protein,Wald ratio,1,1.35 [0.78-2.34],0.282802033015296,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.05 [0.96-1.15],0.283748028279897,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.88 [0.7-1.11],0.28398510473905,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,1.06 [0.95-1.19],0.284943413849267,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.11 [0.91-1.35],0.289549134939864,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.12 [0.9-1.39],0.296659370307242,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.08 [0.93-1.25],0.297514470293821,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANG,Angiogenin,Inverse variance weighted,19,0.95 [0.85-1.05],0.299743750064459,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.03 [0.98-1.08],0.302303958217509,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.37 [0.75-2.48],0.302794493469023,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.19 [0.85-1.68],0.303734791618286,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.9 [0.75-1.1],0.304453618332909,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH2,Cadherin-2,Inverse variance weighted,3,1.3 [0.79-2.14],0.307498504633027,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.94 [0.84-1.06],0.310529506611764,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.92 [0.78-1.08],0.313781221006874,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.88 [0.68-1.13],0.314883360284141,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,1.03 [0.97-1.1],0.315005421826583,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PKD1,Polycystin-1,Inverse variance weighted,12,1.11 [0.91-1.35],0.319283201669651,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.92 [0.79-1.08],0.324254339373472,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PSAP,Prosaposin,Inverse variance weighted,5,1.11 [0.9-1.38],0.32711877966566,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.91 [0.76-1.1],0.328438552626356,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,0.78 [0.47-1.29],0.329555048135939,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.06 [0.94-1.2],0.331876426889084,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.94 [0.83-1.06],0.334634865036891,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.18 [0.84-1.64],0.336125195867654,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL19,Interleukin-19,Inverse variance weighted,11,1.07 [0.93-1.24],0.336564838775215,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.92 [0.79-1.09],0.336692407510292,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,37,1.04 [0.96-1.12],0.340704204293549,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,0.7 [0.33-1.47],0.34239754327853,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.53 [0.14-1.97],0.343842435246264,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.71 [0.56-5.27],0.348974581086758,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,0.89 [0.69-1.14],0.353512475813351,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.05 [0.94-1.18],0.356441560190705,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.09 [0.91-1.29],0.35733249564628,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COLEC12,Collectin-12,Inverse variance weighted,11,1.1 [0.9-1.35],0.359718834687534,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.08 [0.91-1.28],0.360369807703959,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.13 [0.87-1.47],0.360562245283126,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.07 [0.92-1.24],0.362188962194618,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RSPO1,R-spondin-1,Inverse variance weighted,5,1.13 [0.87-1.45],0.364237477158013,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.04 [0.95-1.14],0.365708645530348,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.97 [0.9-1.04],0.3660607441493,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.5 [0.62-3.65],0.366912631133442,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.04 [0.96-1.13],0.36778177648507,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.9 [0.71-1.13],0.368628633235314,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.2 [0.81-1.77],0.369795594258104,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.8 [0.49-1.3],0.37058197360811,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.2 [0.8-1.79],0.370961345969098,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1.08 [0.91-1.27],0.373120548346264,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.97 [0.91-1.03],0.375975097896984,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BSG,Basigin,Wald ratio,1,1.17 [0.82-1.66],0.377177448409826,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCG2,Secretogranin-2,Wald ratio,1,1.59 [0.57-4.46],0.377712479562074,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.06 [0.93-1.21],0.380023552925264,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.07 [0.92-1.25],0.381109831338094,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.96 [0.88-1.05],0.38213234018171,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPPC,C-type natriuretic peptide,Wald ratio,1,0.6 [0.19-1.91],0.383694270255537,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.9 [0.72-1.13],0.385337536986735,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.88 [0.66-1.18],0.387292598611551,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.09 [0.9-1.32],0.389771899721239,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.63 [0.22-1.81],0.391881845115455,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,9,1.08 [0.91-1.27],0.392018345329866,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.97 [0.91-1.04],0.394189897414287,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,22,1.04 [0.95-1.15],0.399152384466014,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CSTB,Cystatin-B,Inverse variance weighted,28,1.04 [0.95-1.15],0.400984809932113,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.1 [0.88-1.38],0.402759553655562,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.89 [0.67-1.17],0.403089331504789,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.83 [0.54-1.29],0.404176861170592,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.03 [0.96-1.11],0.40583614568261,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.15 [0.83-1.58],0.407417282165242,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.93 [0.78-1.1],0.410228737599138,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEPTIN8,Septin-8,Inverse variance weighted,2,0.74 [0.36-1.52],0.41031180094357,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.96 [0.86-1.07],0.410545542644647,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHGB,Secretogranin-1,Inverse variance weighted,27,1.03 [0.95-1.12],0.410547534418529,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.06 [0.92-1.21],0.419813523389517,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.97 [0.91-1.04],0.425505458192642,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,14,0.96 [0.86-1.07],0.425986395543088,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.14 [0.82-1.58],0.430942788247684,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.87 [0.6-1.24],0.431067865355323,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.58 [0.5-4.99],0.432433204512113,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PGA4,Pepsin A-4,Inverse variance weighted,2,1.31 [0.67-2.57],0.434082054227061,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NECTIN4,Nectin-4,Inverse variance weighted,7,1.06 [0.92-1.23],0.436555197703169,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.19 [0.77-1.84],0.437392029276571,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1.04 [0.94-1.14],0.442028061424802,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BOC,Brother of CDO,Inverse variance weighted,6,1.08 [0.88-1.32],0.442779992166613,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.02 [0.96-1.09],0.446487285222706,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,1.36 [0.61-3.06],0.451197198362932,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.07 [0.9-1.28],0.451469137722934,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD160,CD160 antigen,Inverse variance weighted,11,0.94 [0.8-1.1],0.45460823466518,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,9,0.95 [0.83-1.09],0.45805570258504,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GRN,Progranulin,Inverse variance weighted,7,1.06 [0.91-1.24],0.458210481498951,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.04 [0.93-1.16],0.468460823811712,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.05 [0.92-1.19],0.470023820801961,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MFGE8,Lactadherin,Inverse variance weighted,11,1.05 [0.91-1.22],0.474124912637452,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ELN,Elastin,Inverse variance weighted,2,1.26 [0.67-2.38],0.477492104419776,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.95 [0.83-1.09],0.478005391694816,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.03 [0.95-1.12],0.478044280619019,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.03 [0.95-1.11],0.479240642827358,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.89 [0.65-1.22],0.482448131826315,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.08 [0.87-1.35],0.482834852264821,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IFNL1,Interferon lambda-1,Wald ratio,1,0.67 [0.22-2.06],0.486024973376816,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,0.95 [0.83-1.09],0.487015736921993,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPP1,Osteopontin,Inverse variance weighted,8,1.17 [0.75-1.81],0.48851739293697,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.94 [0.79-1.12],0.492254692351691,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.91 [0.7-1.18],0.49229112361995,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.92 [0.72-1.17],0.493210825305872,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.08 [0.87-1.33],0.493652898776532,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD27,CD27 antigen,Inverse variance weighted,9,1.07 [0.88-1.3],0.500180886284156,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.05 [0.91-1.22],0.502976430416152,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DPT,Dermatopontin,Inverse variance weighted,21,1.05 [0.91-1.2],0.508285085909064,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.11 [0.82-1.49],0.509488109727119,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.86 [0.55-1.35],0.510185819681365,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.36 [0.54-3.43],0.510205211084673,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.1 [0.83-1.45],0.514232461960077,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.03 [0.94-1.14],0.515099344752249,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.12 [0.8-1.56],0.515800274311742,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PI16,Peptidase inhibitor 16,Inverse variance weighted,15,0.96 [0.83-1.1],0.516722188959006,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.74 [0.3-1.82],0.516957903816049,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSL,Cathepsin L1,Wald ratio,1,0.71 [0.25-2.03],0.517980477041851,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.14 [0.76-1.73],0.519926454125154,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,1.09 [0.84-1.42],0.52001981617939,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,OGN,Mimecan,Inverse variance weighted,30,1.03 [0.94-1.14],0.52055344503647,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.86 [0.55-1.36],0.52096888465373,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAYN,Layilin,Inverse variance weighted,20,0.95 [0.82-1.1],0.522650748467662,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRSS2,Trypsin-2,Inverse variance weighted,3,1.12 [0.79-1.58],0.52347602188885,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.02 [0.96-1.08],0.524112327030173,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.96 [0.84-1.09],0.526368820367678,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,0.98 [0.92-1.04],0.527493904023642,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.96 [0.84-1.09],0.533657036720859,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.96 [0.83-1.1],0.534740540856525,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MATN2,Matrilin-2,Inverse variance weighted,18,1.06 [0.89-1.26],0.535344802080179,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,1.56 [0.38-6.41],0.540019456227079,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.94 [0.78-1.14],0.540184374718076,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.06 [0.88-1.28],0.540959476591373,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,APOA2,Apolipoprotein A-II,Wald ratio,1,0.8 [0.38-1.66],0.542267311580007,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,0.96 [0.83-1.1],0.544626953927303,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.03 [0.93-1.16],0.545926500003898,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.78 [0.35-1.76],0.549216577816266,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1.09 [0.82-1.46],0.552031380806857,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.04 [0.92-1.17],0.552899727034491,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANXA5,Annexin A5,Inverse variance weighted,2,0.87 [0.55-1.38],0.555033653398278,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AFP,Alpha-fetoprotein,Inverse variance weighted,5,0.92 [0.69-1.22],0.556186615671983,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.95 [0.82-1.12],0.560780204488847,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,0.97 [0.89-1.06],0.561026127608277,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.16 [0.71-1.89],0.562841988914248,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ENAH,Protein enabled homolog,Inverse variance weighted,2,0.88 [0.58-1.35],0.56396424433543,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.88 [0.57-1.36],0.566460171921179,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK10,Kallikrein-10,Inverse variance weighted,15,0.95 [0.81-1.12],0.568306624196242,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,1.04 [0.92-1.17],0.570142911405455,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.72 [0.24-2.22],0.570405852823252,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.02 [0.95-1.1],0.570641247767581,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.77 [0.3-1.93],0.570890301898995,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ROBO4,Roundabout homolog 4,Wald ratio,1,0.85 [0.49-1.48],0.571286321647418,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.06 [0.87-1.3],0.573110134294051,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CALCA,Calcitonin,Inverse variance weighted,5,1.11 [0.76-1.62],0.573343723566926,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.04 [0.92-1.17],0.574047611190956,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EGFLAM,Pikachurin,Inverse variance weighted,19,0.98 [0.9-1.06],0.578407119129127,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,C7,Complement component C7,Inverse variance weighted,38,1.02 [0.96-1.08],0.578957708998725,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.97 [0.88-1.07],0.584847273919159,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.98 [0.92-1.05],0.585210494898854,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.92 [0.67-1.26],0.586933620494454,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.97 [0.85-1.09],0.589470728767667,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CALB1,Calbindin,Inverse variance weighted,2,1.17 [0.67-2.05],0.591045864670204,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCG3,Secretogranin-3,Inverse variance weighted,32,0.97 [0.86-1.09],0.591080256397018,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.95 [0.78-1.15],0.592478833843739,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.74 [0.24-2.25],0.593061874138093,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,0.96 [0.84-1.1],0.593461883145908,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.89 [0.56-1.39],0.599743052590331,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.06 [0.86-1.3],0.602054041408561,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MMP7,Matrilysin,Inverse variance weighted,13,1.03 [0.91-1.18],0.603272015209222,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,1.02 [0.93-1.12],0.60507810937965,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGALS9,Galectin-9,Inverse variance weighted,26,0.97 [0.87-1.09],0.606174110319777,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,0.9 [0.62-1.32],0.607156140457446,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.94 [0.75-1.18],0.607454825609651,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.02 [0.94-1.11],0.608153675334699,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.36 [0.42-4.36],0.608688411646521,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DRAXIN,Draxin,Inverse variance weighted,13,1.03 [0.92-1.16],0.609221949650268,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.97 [0.87-1.09],0.614814564380655,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.98 [0.89-1.07],0.619461204208699,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.97 [0.86-1.09],0.620659048364778,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.04 [0.88-1.24],0.622054507351998,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,0.87 [0.49-1.53],0.623539767278809,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.98 [0.92-1.05],0.627223182049471,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,1.2 [0.57-2.55],0.632754001032572,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.07 [0.8-1.44],0.632972224020821,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.88 [0.51-1.5],0.634276436981988,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NXPH3,Neurexophilin-3,Inverse variance weighted,11,0.97 [0.84-1.11],0.636770642250265,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,1.33 [0.41-4.35],0.639644789301739,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PGF,Placenta growth factor,Inverse variance weighted,2,0.61 [0.08-4.94],0.642453267114864,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.97 [0.84-1.12],0.642777518895614,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VGF,Neurosecretory protein VGF,Wald ratio,1,0.73 [0.19-2.76],0.643794588065276,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AGRP,Agouti-related protein,Inverse variance weighted,3,1.12 [0.68-1.86],0.647080416878693,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,36,0.98 [0.9-1.07],0.648240408854443,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,29,0.98 [0.89-1.08],0.653849614919661,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.89 [0.53-1.49],0.654668116670358,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.94 [0.74-1.21],0.655011913948917,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.16 [0.61-2.2],0.655638266821332,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,1.08 [0.77-1.53],0.659612268699372,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.03 [0.91-1.17],0.661178552490614,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AMBP,Protein AMBP,Inverse variance weighted,3,0.93 [0.67-1.29],0.666297084208518,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PENK,Proenkephalin-A,Inverse variance weighted,19,1.04 [0.88-1.23],0.667764203136321,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.06 [0.8-1.4],0.667911768582853,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSH,Pro-cathepsin H,Inverse variance weighted,33,0.99 [0.93-1.05],0.671463650778389,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK11,Kallikrein-11,Inverse variance weighted,6,0.97 [0.84-1.12],0.671946950268805,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MMP3,Stromelysin-1,Inverse variance weighted,34,0.98 [0.88-1.09],0.67315940154902,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,F3,Tissue factor,Inverse variance weighted,11,0.96 [0.8-1.15],0.673998046799328,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.18 [0.55-2.5],0.674118827139688,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,1.03 [0.9-1.18],0.67438875402311,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.03 [0.89-1.19],0.677342539773977,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,19,1.03 [0.9-1.18],0.678518865680992,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGALS4,Galectin-4,Inverse variance weighted,4,1.08 [0.74-1.6],0.679400888396319,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP6,Gastrotropin,Wald ratio,1,1.08 [0.75-1.56],0.680072588537065,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,1.15 [0.6-2.21],0.681404655081318,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGALS1,Galectin-1,Inverse variance weighted,6,1.04 [0.85-1.27],0.687112760161673,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.92 [0.61-1.38],0.687283454417326,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.96 [0.81-1.15],0.689672594219693,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRSS27,Serine protease 27,Inverse variance weighted,5,0.95 [0.76-1.2],0.690135099749703,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AGRN,Agrin,Inverse variance weighted,17,0.97 [0.83-1.13],0.691330057461435,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.02 [0.93-1.12],0.692173037584576,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REN,Renin,Inverse variance weighted,4,1.04 [0.86-1.26],0.692618103795267,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH6,Cadherin-6,Inverse variance weighted,29,1.02 [0.94-1.11],0.692902991878302,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,1.02 [0.91-1.15],0.693051333732987,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHAD,Chondroadherin,Inverse variance weighted,3,0.97 [0.84-1.13],0.693079929090404,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.1 [0.68-1.79],0.695058068721075,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.02 [0.92-1.13],0.696592223278361,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.04 [0.85-1.28],0.702784656336825,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,0.99 [0.91-1.06],0.703794639002972,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,1.01 [0.94-1.09],0.703912916570541,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL10,Interleukin-10,Wald ratio,1,1.1 [0.68-1.76],0.706038547001374,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,1.03 [0.88-1.21],0.706903276511365,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,XCL1,Lymphotactin,Inverse variance weighted,31,0.99 [0.92-1.06],0.708851976721441,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,0.98 [0.86-1.11],0.712085483781392,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.93 [0.65-1.34],0.713394047988444,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.02 [0.94-1.1],0.714840750520435,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ITGB6,Integrin beta-6,Inverse variance weighted,11,0.97 [0.85-1.12],0.716111786333627,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RTBDN,Retbindin,Inverse variance weighted,3,0.95 [0.7-1.28],0.718341366141204,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PALM,Paralemmin-1,Inverse variance weighted,6,0.95 [0.7-1.28],0.719864440868458,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.04 [0.84-1.29],0.720826078832588,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,0.99 [0.91-1.07],0.72551054762407,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LCN15,Lipocalin-15,Inverse variance weighted,20,1.02 [0.93-1.11],0.727433965245048,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.97 [0.83-1.14],0.732117634357016,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.94 [0.65-1.35],0.733475595075647,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.02 [0.91-1.14],0.733610810659038,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.97 [0.8-1.17],0.734043993358304,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,1.02 [0.92-1.12],0.73558360170555,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.95 [0.68-1.31],0.73767290508265,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.92-1.06],0.740696532154136,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.89 [0.43-1.82],0.742690608308096,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.04 [0.82-1.31],0.744849393462042,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.98 [0.85-1.12],0.747586695694323,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,1.08 [0.66-1.79],0.750772221980684,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,0.99 [0.92-1.06],0.751750391453414,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK6,Kallikrein-6,Inverse variance weighted,4,1.04 [0.82-1.32],0.752588206454146,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CST6,Cystatin-M,Inverse variance weighted,2,0.91 [0.51-1.63],0.755154081249847,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.96 [0.74-1.24],0.755461930664342,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GPC1,Glypican-1,Inverse variance weighted,17,1.02 [0.9-1.16],0.755495007658479,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PALM2,Paralemmin-2,Inverse variance weighted,8,1.03 [0.85-1.25],0.756794077768927,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.83 [0.25-2.77],0.761400192350761,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AREG,Amphiregulin,Inverse variance weighted,3,0.95 [0.66-1.36],0.76155522965166,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL17D,Interleukin-17D,Inverse variance weighted,15,1.02 [0.89-1.18],0.761708866837363,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.93 [0.58-1.49],0.76525318146414,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCN3,CCN family member 3,Inverse variance weighted,19,0.98 [0.85-1.13],0.768120194794066,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLGN,Calmegin,Inverse variance weighted,23,1.01 [0.93-1.11],0.768566253452652,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.04 [0.78-1.39],0.771551554898707,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NECTIN2,Nectin-2,Inverse variance weighted,5,0.98 [0.85-1.13],0.772154959279021,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.02 [0.91-1.13],0.780883060852304,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.07 [0.65-1.77],0.782859454334162,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.95-1.07],0.783394736550768,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.04 [0.8-1.35],0.783808713630214,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.83 [0.21-3.21],0.783860382018497,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.98 [0.88-1.1],0.784427183509475,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.88 [0.36-2.18],0.784500404402715,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.96 [0.74-1.25],0.785271348582605,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,1.02 [0.9-1.14],0.787618825422027,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.97 [0.76-1.23],0.787776445771826,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.02 [0.89-1.17],0.788795710343943,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1.01 [0.96-1.06],0.790289308953757,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.05 [0.74-1.49],0.790547394772856,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CST3,Cystatin-C,Inverse variance weighted,10,1.02 [0.88-1.18],0.791377776877991,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RGMB,RGM domain family member B,Inverse variance weighted,9,1.04 [0.8-1.35],0.79320496900922,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.95 [0.67-1.37],0.794668360141947,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.02 [0.86-1.21],0.797406445877451,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.02 [0.86-1.23],0.798535420686318,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.04 [0.76-1.43],0.798835593451398,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,1.04 [0.76-1.44],0.801343045991163,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD83,CD83 antigen,Inverse variance weighted,5,1.06 [0.68-1.63],0.805676817323273,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,0.99 [0.92-1.07],0.807379013026546,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RBP2,Retinol-binding protein 2,Wald ratio,1,1.1 [0.5-2.46],0.807706254318318,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.94 [0.55-1.6],0.808036621986267,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,0.98 [0.83-1.16],0.808207005661569,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,1.01 [0.94-1.08],0.809381319674887,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.95 [0.65-1.41],0.812980212757351,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.01 [0.93-1.1],0.813427544080461,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MUC13,Mucin-13,Inverse variance weighted,9,1.02 [0.84-1.24],0.820481194184265,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.06 [0.64-1.75],0.822442306026892,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.03 [0.78-1.37],0.825067664989339,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.86 [0.22-3.37],0.825954506484563,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.04 [0.74-1.45],0.829644401639589,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.99 [0.89-1.09],0.829894048962596,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD164,Sialomucin core protein 24,Inverse variance weighted,3,0.97 [0.72-1.3],0.831445385830386,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.92 [0.41-2.04],0.832686153706392,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,7,0.97 [0.75-1.26],0.835013118247792,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.01 [0.93-1.09],0.835681578715245,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1.05 [0.64-1.75],0.836411655261485,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.02 [0.87-1.19],0.837011050996011,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.97 [0.7-1.33],0.841064339337734,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.99 [0.86-1.13],0.841907160479959,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.95 [0.6-1.51],0.842963569093498,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.03 [0.8-1.32],0.843750287161935,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.02 [0.82-1.27],0.84493439844989,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,18,0.99 [0.92-1.07],0.845258731698665,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.94 [0.48-1.84],0.849157514429795,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.98 [0.75-1.27],0.851436548385096,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.01 [0.9-1.13],0.851698159701095,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHGA,Chromogranin-A,Inverse variance weighted,3,0.98 [0.76-1.25],0.852138096974872,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.95 [0.55-1.64],0.859128914885916,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,S100P,Protein S100-P,Inverse variance weighted,2,1.06 [0.55-2.05],0.859331803087822,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRSS8,Prostasin,Inverse variance weighted,5,0.97 [0.67-1.39],0.859351290839246,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.98 [0.83-1.17],0.859798713876122,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.95 [0.56-1.64],0.863905557553614,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ALCAM,CD166 antigen,Inverse variance weighted,6,0.97 [0.72-1.32],0.866316132762949,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.03 [0.74-1.44],0.870634798507085,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.05 [0.59-1.88],0.873912382817641,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGALS3,Galectin-3,Inverse variance weighted,25,0.99 [0.84-1.16],0.875764393908283,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.99 [0.86-1.13],0.876253964803216,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1.01 [0.91-1.12],0.877148262877471,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,1.02 [0.75-1.39],0.878494784198233,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.99 [0.86-1.13],0.88518695938575,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,0.98 [0.74-1.3],0.885301449212627,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.93-1.09],0.886628442238157,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GUCA2A,Guanylin,Inverse variance weighted,9,0.98 [0.79-1.22],0.886713485181116,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.01 [0.9-1.12],0.886942905178474,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,0.99 [0.88-1.11],0.887374865645514,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.03 [0.7-1.52],0.888430018512129,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.99 [0.9-1.09],0.888547788252661,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.86-1.14],0.889516892748013,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.01 [0.89-1.14],0.889842813655477,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.98 [0.78-1.24],0.890813058755951,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.01 [0.83-1.24],0.89600681010256,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.98 [0.68-1.41],0.897504712266962,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.01 [0.93-1.09],0.898222704589069,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.97 [0.59-1.59],0.902175448556545,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH1,Cadherin-1,Wald ratio,1,0.94 [0.33-2.66],0.903447689608981,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1 [0.92-1.07],0.908007927912604,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DSG3,Desmoglein-3,Inverse variance weighted,7,1.01 [0.83-1.24],0.909453368419959,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.01 [0.87-1.16],0.909731001521951,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.92-1.09],0.911407427584556,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TMSB10,Thymosin beta-10,Wald ratio,1,1.05 [0.45-2.42],0.914995977426785,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH17,Cadherin-17,Inverse variance weighted,14,0.99 [0.84-1.17],0.917011319438457,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PI3,Elafin,Inverse variance weighted,10,1.01 [0.85-1.2],0.919928926756719,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.01 [0.79-1.29],0.920346449443874,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.01 [0.79-1.3],0.920825107141921,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.02 [0.68-1.53],0.923998840016259,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.96 [0.43-2.15],0.924553908807133,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSB,Cathepsin B,Inverse variance weighted,26,1 [0.92-1.09],0.928420467761627,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1 [0.94-1.06],0.930349065435053,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VASN,Vasorin,Inverse variance weighted,14,1 [0.91-1.09],0.930958323885838,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.01 [0.87-1.17],0.933304489251475,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.99 [0.71-1.38],0.934295879017046,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1 [0.9-1.1],0.93511230807541,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCN5,CCN family member 5,Inverse variance weighted,8,0.98 [0.67-1.44],0.936947815459866,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1 [0.91-1.11],0.940758838459375,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.01 [0.7-1.46],0.942943461373122,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.99 [0.79-1.25],0.943111152596367,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,THBS2,Thrombospondin-2,Inverse variance weighted,16,1 [0.9-1.11],0.944417701591491,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCN4,CCN family member 4,Inverse variance weighted,27,1 [0.91-1.09],0.946285711346217,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RETN,Resistin,Inverse variance weighted,9,1.01 [0.86-1.18],0.947292209413837,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.99 [0.77-1.27],0.94935946430527,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.99 [0.66-1.48],0.949570695008783,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.03 [0.36-2.94],0.950878981391769,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MB,Myoglobin,Wald ratio,1,1.04 [0.29-3.79],0.950911185008713,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.01 [0.79-1.28],0.954564033169612,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.01 [0.77-1.32],0.95856410655348,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1 [0.86-1.17],0.959346106080461,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.99 [0.76-1.29],0.959849117932457,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AHNAK2,Protein AHNAK2,Inverse variance weighted,4,1 [0.81-1.23],0.96597497404649,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1 [0.82-1.21],0.970807230912941,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1 [0.86-1.16],0.971944534145493,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,1 [0.84-1.19],0.973300067527407,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD302,CD302 antigen,Inverse variance weighted,9,1 [0.85-1.18],0.974476083761348,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1 [0.81-1.24],0.975793464780848,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,0.99 [0.7-1.42],0.976036259978653,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.99 [0.59-1.67],0.977817171647346,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1 [0.91-1.1],0.977865113371757,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MDK,Midkine,Inverse variance weighted,4,1 [0.73-1.38],0.982506265218853,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD48,CD48 antigen,Inverse variance weighted,18,1 [0.92-1.08],0.983133846781074,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RSPO3,R-spondin-3,Inverse variance weighted,6,1 [0.75-1.33],0.984228566893451,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPON2,Spondin-2,Inverse variance weighted,4,1 [0.77-1.29],0.985531652790796,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1 [0.79-1.26],0.988211203441684,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1 [0.85-1.19],0.988842687471684,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1 [0.73-1.37],0.989667076625194,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1 [0.56-1.78],0.991802367271273,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,1 [0.82-1.22],0.992126852724475,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1 [0.76-1.31],0.993766141884899,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRELP,Prolargin,Inverse variance weighted,9,1 [0.87-1.15],0.994142568050424,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1 [0.67-1.48],0.995524692583442,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK8,Kallikrein-8,Inverse variance weighted,12,1 [0.86-1.16],0.995562184888179,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1 [0.41-2.43],0.999971275928645,cis
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFNA1,Ephrin-A1,Inverse variance weighted,3,2.49 [1.51-4.1],0.000337486813451867,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGMN,Legumain,Inverse variance weighted,22,1.44 [1.15-1.8],0.00123198178953392,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.15 [1.05-1.25],0.00140955369253416,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.98 [1.29-3.03],0.00173056159214378,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.35 [0.18-0.68],0.00192320790273115,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,2.02 [1.25-3.28],0.00428860813650246,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,2.14 [1.26-3.66],0.0050901545611493,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.66 [0.48-0.89],0.00595357577650233,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CALCA,Calcitonin,Inverse variance weighted,13,0.65 [0.47-0.88],0.00632973755412322,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.92 [0.86-0.98],0.0063811290984392,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,1.15 [1.04-1.27],0.00694418228447498,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.15 [1.04-1.28],0.00729257644808734,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGALS3,Galectin-3,Inverse variance weighted,15,1.59 [1.13-2.25],0.00835791216852285,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.71 [0.55-0.92],0.00837008551883918,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.29 [1.06-1.57],0.0126180898917019,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.4 [1.07-1.83],0.0137677224406732,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD276,CD276 antigen,Inverse variance weighted,24,1.22 [1.04-1.43],0.0141662493649741,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RTBDN,Retbindin,Inverse variance weighted,2,2.24 [1.17-4.28],0.0143305387798544,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.78 [0.64-0.95],0.0150169530278963,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.76 [0.61-0.95],0.0174237752253465,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,3.47 [1.24-9.69],0.0174648909156022,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NECTIN2,Nectin-2,Inverse variance weighted,3,3.53 [1.22-10.2],0.0196121113631912,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,2.1 [1.13-3.93],0.0196972201738856,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,2.39 [1.15-5],0.0200747060546066,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DPT,Dermatopontin,Inverse variance weighted,4,0.51 [0.28-0.92],0.0247305612036765,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,2.26 [1.1-4.63],0.0258776751650874,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,1.37 [1.04-1.8],0.0261038427770053,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.35 [1.03-1.77],0.0274675989129146,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MMP10,Stromelysin-2,Wald ratio,1,0.25 [0.07-0.87],0.0288215873194314,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.77 [0.6-0.98],0.0308327262220816,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.45 [1.03-2.04],0.0310203720931357,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,WNT9A,Protein Wnt-9a,Wald ratio,1,4.47 [1.15-17.46],0.0311021375304365,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.85 [0.74-0.99],0.0345507869437447,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.32 [1.02-1.72],0.0370457353328232,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.46 [0.22-0.97],0.0401082015307735,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.11 [1-1.22],0.042938902362511,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,1.21 [1-1.46],0.0451410301993351,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.42 [1-2.03],0.0525046913657975,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HEPH,Hephaestin,Inverse variance weighted,6,1.23 [1-1.53],0.0532396580586029,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.82 [0.68-1],0.0532715080234171,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.76 [0.57-1],0.0537959692950613,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PALM,Paralemmin-1,Inverse variance weighted,4,0.63 [0.4-1.01],0.0552356268298648,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,0.33 [0.11-1.04],0.0594596289910137,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.26 [0.99-1.6],0.0630686961778181,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.76 [0.56-1.02],0.0633686083117265,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MDK,Midkine,Inverse variance weighted,14,0.79 [0.61-1.01],0.064955643303057,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,THBD,Thrombomodulin,Inverse variance weighted,11,1.31 [0.98-1.74],0.0670797433667519,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL15,Interleukin-15,Inverse variance weighted,35,1.15 [0.99-1.34],0.0679805305055576,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NGRN,Neugrin,Inverse variance weighted,4,1.5 [0.97-2.32],0.0680288486726857,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.49 [0.97-2.29],0.0683877640587779,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.3 [0.98-1.73],0.0707673151210988,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.15 [0.99-1.34],0.0743702119873544,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.61 [0.35-1.05],0.0744779496029862,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.45 [0.96-2.2],0.0759913483411009,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,1.34 [0.97-1.87],0.0760410951375982,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.26 [0.97-1.63],0.0792357058043746,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ITGB2,Integrin beta-2,Inverse variance weighted,20,0.86 [0.72-1.02],0.080143955923501,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,2.12 [0.91-4.92],0.0807543035658752,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PI16,Peptidase inhibitor 16,Inverse variance weighted,22,0.89 [0.78-1.01],0.0808222595709235,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.3 [0.97-1.75],0.0809708117316522,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,0.45 [0.18-1.11],0.0825725733235772,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.36 [0.96-1.92],0.0836996093329556,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.91 [0.81-1.01],0.0852270096936085,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.16 [0.98-1.37],0.0861985375289723,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.17 [0.98-1.41],0.0869437979081913,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.17 [0.98-1.4],0.0874467439310324,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,1.04 [0.99-1.08],0.0896365366064259,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.59 [0.93-2.72],0.0898678388620668,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.79 [0.6-1.04],0.0921932911028581,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.8 [0.89-3.65],0.10135537170128,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.3 [0.95-1.79],0.102981587428076,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.36 [0.94-1.97],0.103799112069727,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.72 [0.49-1.07],0.105736161276973,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.54 [0.26-1.14],0.106223406307998,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CST3,Cystatin-C,Inverse variance weighted,3,1.72 [0.89-3.31],0.107928337075288,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.69 [0.44-1.09],0.108312447865622,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MMP3,Stromelysin-1,Inverse variance weighted,4,0.59 [0.31-1.13],0.111104368796672,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.76 [0.55-1.06],0.111416433890668,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.72 [0.49-1.08],0.113919978309819,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.73 [0.87-3.44],0.116675380069045,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.56 [0.89-2.73],0.120810395728197,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.08 [0.98-1.19],0.121449661172199,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.93 [0.84-1.02],0.122555365778048,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,0.73 [0.49-1.09],0.122558566100462,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NXPH3,Neurexophilin-3,Inverse variance weighted,19,0.92 [0.82-1.02],0.123857493334963,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,2.08 [0.81-5.31],0.125564630777367,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,S100P,Protein S100-P,Inverse variance weighted,4,1.34 [0.92-1.96],0.127786818601755,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.32 [0.92-1.88],0.131189563408728,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.35 [0.91-1.98],0.132227343916214,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.2 [0.95-1.53],0.132555447923113,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.9 [0.78-1.03],0.133510707806189,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,0.84 [0.66-1.06],0.134664080365401,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCG2,Secretogranin-2,Inverse variance weighted,2,1.59 [0.86-2.93],0.136271700788775,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.59 [0.86-2.94],0.137815627439693,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.16 [0.95-1.41],0.138002164381752,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.8 [0.59-1.08],0.138166507742307,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD27,CD27 antigen,Inverse variance weighted,9,1.32 [0.91-1.92],0.138919084376526,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPP1,Osteopontin,Inverse variance weighted,13,1.25 [0.93-1.68],0.140870504261569,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.82 [0.63-1.07],0.144487668667734,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,UMOD,Uromodulin,Inverse variance weighted,34,1.13 [0.96-1.32],0.145356462569516,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.2 [0.94-1.53],0.145436243157807,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.23 [0.93-1.63],0.146928972263826,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BSG,Basigin,Inverse variance weighted,6,1.52 [0.86-2.67],0.149320524893614,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.32 [0.9-1.92],0.150799505874715,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.7 [0.43-1.14],0.154162923565535,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DSC2,Desmocollin-2,Inverse variance weighted,16,0.9 [0.78-1.04],0.155035918292944,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.82 [0.63-1.08],0.155880282091331,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.58 [0.84-2.95],0.156387363020041,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.14 [0.95-1.37],0.156633864646768,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.15 [0.95-1.39],0.156804716790235,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK6,Kallikrein-6,Inverse variance weighted,2,1.91 [0.78-4.65],0.157157867356328,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.84 [0.67-1.07],0.160853819970455,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.35 [0.88-2.07],0.162464405098335,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.27 [0.91-1.78],0.164231718201819,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DSG2,Desmoglein-2,Inverse variance weighted,22,1.12 [0.96-1.31],0.165011399652563,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MB,Myoglobin,Inverse variance weighted,9,0.72 [0.45-1.15],0.169252060230992,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAYN,Layilin,Inverse variance weighted,3,2.42 [0.69-8.5],0.169509056482613,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CFC1,Cryptic protein,Inverse variance weighted,11,0.77 [0.53-1.12],0.169866671210476,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH6,Cadherin-6,Inverse variance weighted,5,1.4 [0.86-2.27],0.172928891207171,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GRN,Progranulin,Inverse variance weighted,46,0.94 [0.87-1.03],0.17392184888987,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLAMF7,SLAM family member 7,Inverse variance weighted,16,0.87 [0.71-1.06],0.174615676559334,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.76 [0.5-1.13],0.176394545857672,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL17D,Interleukin-17D,Inverse variance weighted,2,1.9 [0.75-4.81],0.177509004153874,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ALCAM,CD166 antigen,Inverse variance weighted,4,0.8 [0.58-1.11],0.183264524348186,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AGRP,Agouti-related protein,Inverse variance weighted,16,0.87 [0.7-1.07],0.183472205682063,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.09 [0.96-1.23],0.185163913951949,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.33 [0.87-2.01],0.185964366340929,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.33 [0.87-2.02],0.186406666251707,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.35 [0.86-2.13],0.1912493754607,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.39 [0.84-2.31],0.196444725068829,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.06 [0.97-1.16],0.196641181321292,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,17,0.9 [0.76-1.06],0.196888319561988,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.59 [0.78-3.24],0.196996232253554,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.58 [0.25-1.34],0.199827838117069,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.14 [0.93-1.4],0.200419365434018,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NFASC,Neurofascin,Inverse variance weighted,6,0.7 [0.41-1.21],0.200903101075068,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,23,1.1 [0.95-1.26],0.201097813113537,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,F2R,Proteinase-activated receptor 1,Inverse variance weighted,6,1.26 [0.88-1.82],0.204705769259802,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,F3,Tissue factor,Inverse variance weighted,13,0.77 [0.52-1.15],0.204724092063179,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,22,1.12 [0.94-1.34],0.207665536148937,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.63 [0.76-3.5],0.209266591330915,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.11 [0.94-1.31],0.209993816353392,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ITGB6,Integrin beta-6,Inverse variance weighted,16,0.87 [0.7-1.08],0.210068933796099,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.11 [0.94-1.32],0.211620984773307,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,1.68 [0.74-3.79],0.211750928555193,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MILR1,Allergin-1,Inverse variance weighted,43,0.96 [0.91-1.02],0.212329491985189,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,0.85 [0.66-1.1],0.216064148635591,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL16,Pro-interleukin-16,Inverse variance weighted,6,1.37 [0.83-2.28],0.216615345173113,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.29 [0.86-1.92],0.217532384638956,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,0.88 [0.71-1.08],0.219365439365488,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.68 [0.37-1.26],0.223745415346681,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.82 [0.6-1.13],0.223822550784883,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.09 [0.95-1.26],0.224401068664753,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.11 [0.94-1.32],0.228414534339791,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.36 [0.82-2.26],0.231486693708763,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.12 [0.93-1.35],0.233194253700241,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.36 [0.82-2.27],0.238115443692945,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.47 [0.77-2.79],0.23836871469502,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.57 [0.74-3.31],0.238984189801805,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.84 [0.62-1.13],0.240067485604653,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.81 [0.67-4.91],0.240869621509756,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.1 [0.94-1.3],0.244004106417886,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,0.92 [0.8-1.06],0.24510506796834,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.94 [0.85-1.04],0.245846751045983,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH2,Cadherin-2,Inverse variance weighted,21,1.12 [0.92-1.36],0.25809985074626,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.4 [0.78-2.54],0.261485234631984,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.09 [0.94-1.26],0.26931380002312,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL11,Eotaxin,Inverse variance weighted,11,1.11 [0.92-1.32],0.269978145139002,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AREG,Amphiregulin,Inverse variance weighted,5,1.56 [0.71-3.42],0.270525687655037,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.31 [0.81-2.1],0.271503882627781,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.93 [0.83-1.05],0.272043693079016,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,1.39 [0.77-2.48],0.272609903437602,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.7 [0.37-1.33],0.274966818326452,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,1.07 [0.95-1.21],0.276345079648434,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.16 [0.89-1.52],0.278198786483762,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.8 [0.53-1.2],0.279600105546335,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.94 [0.85-1.05],0.280461112820926,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,1.17 [0.88-1.56],0.280496651128485,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.76 [0.45-1.26],0.281114113840456,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.49 [0.72-3.08],0.281621168213465,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.18 [0.87-1.6],0.281972987107642,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AGRN,Agrin,Inverse variance weighted,14,1.18 [0.87-1.61],0.283335908233702,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MUC13,Mucin-13,Inverse variance weighted,3,1.44 [0.74-2.8],0.283588216352881,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DCN,Decorin,Inverse variance weighted,2,1.58 [0.68-3.69],0.284907003672988,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.67 [0.32-1.4],0.285723025544921,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GUCA2A,Guanylin,Inverse variance weighted,7,0.79 [0.52-1.21],0.286212225415357,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,0.82 [0.57-1.18],0.286224370001016,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.85 [0.62-1.15],0.287463425366704,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL17C,Interleukin-17C,Inverse variance weighted,5,1.29 [0.8-2.08],0.289049471466824,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,XG,Glycoprotein Xg,Inverse variance weighted,2,0.65 [0.29-1.45],0.290336487309886,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.15 [0.89-1.48],0.291252900367493,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.37 [0.76-2.45],0.292158293824197,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CST6,Cystatin-M,Inverse variance weighted,26,1.12 [0.9-1.39],0.292238170023404,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH1,Cadherin-1,Inverse variance weighted,16,0.9 [0.74-1.1],0.293985503582918,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,0.52 [0.15-1.76],0.294339354291589,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.15 [0.89-1.48],0.294691612144652,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VASN,Vasorin,Inverse variance weighted,5,1.52 [0.69-3.34],0.294704938564201,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.92 [0.78-1.08],0.296832433240316,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.83 [0.59-1.18],0.297199051674586,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.13 [0.9-1.42],0.298280869381516,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRSS27,Serine protease 27,Inverse variance weighted,47,1.05 [0.96-1.15],0.30189023817741,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.05 [0.96-1.15],0.302547076390124,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.06 [0.95-1.2],0.303590190364823,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.88 [0.68-1.13],0.304657558235015,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.93 [0.82-1.07],0.306865972353519,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.09 [0.92-1.29],0.308036320379578,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GPC1,Glypican-1,Inverse variance weighted,28,0.92 [0.79-1.08],0.308669815409711,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.07 [0.94-1.23],0.310066444892532,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.43 [0.72-2.85],0.310293655654185,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPON1,Spondin-1,Inverse variance weighted,4,1.29 [0.78-2.13],0.31307632006774,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,0.8 [0.51-1.24],0.316434315676489,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.79 [0.49-1.26],0.318292979606082,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.08 [0.93-1.26],0.318732821027526,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.79 [0.5-1.26],0.318932480621761,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.18 [0.85-1.64],0.319128448044818,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.12 [0.9-1.4],0.32092902714367,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.75 [0.42-1.33],0.32302690203631,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.58 [0.2-1.71],0.324131150317091,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSO,Cathepsin O,Inverse variance weighted,19,1.08 [0.92-1.27],0.324843806255929,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.94 [0.83-1.06],0.325065084493321,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.35 [0.74-2.45],0.328016002054548,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD48,CD48 antigen,Inverse variance weighted,14,0.83 [0.57-1.2],0.328355071492741,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.57 [0.19-1.76],0.330158712762843,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.88 [0.67-1.15],0.331477229092218,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.78 [0.46-1.3],0.332067307459283,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.13 [0.88-1.44],0.332170807041488,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,0.92 [0.79-1.09],0.334443362492895,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,1.73 [0.57-5.29],0.336988662117729,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.12 [0.89-1.42],0.338175976062906,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FAM3D,Protein FAM3D,Inverse variance weighted,38,0.94 [0.83-1.06],0.338401029018066,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,1.11 [0.89-1.39],0.338609640428989,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,0.78 [0.47-1.29],0.340117641478373,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.15 [0.87-1.52],0.340911857496285,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.19 [0.83-1.72],0.345270532237594,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.97 [0.91-1.03],0.34630039278533,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.23 [0.8-1.88],0.348688112841533,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.94 [0.83-1.07],0.349200676789275,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.18 [0.84-1.66],0.349768661841248,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,1.36 [0.71-2.61],0.350786984832087,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.69 [0.31-1.51],0.351211307553998,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.83 [0.51-6.64],0.356199780026076,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.91 [0.75-1.11],0.356530368314716,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.11 [0.89-1.38],0.357458644357387,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.84 [0.59-1.21],0.357847765950654,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.08 [0.92-1.26],0.358896240302023,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.83 [0.56-1.23],0.359157804403107,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,3,0.75 [0.4-1.39],0.359779719883672,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.07 [0.93-1.23],0.362688050247112,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.04 [0.95-1.13],0.369495285794384,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,0.91 [0.75-1.11],0.371102180988304,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.21 [0.8-1.83],0.376717732650971,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CSTB,Cystatin-B,Inverse variance weighted,23,1.04 [0.95-1.15],0.378182727939827,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.87 [0.65-1.18],0.378315567995814,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,1.09 [0.9-1.32],0.378414103119732,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.86 [0.61-1.21],0.381583507032766,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.94 [0.83-1.07],0.381979969615529,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.77 [0.44-1.38],0.382170441462511,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.09 [0.9-1.31],0.385148332900473,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.04 [0.95-1.14],0.385183245549459,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SERPINB8,Serpin B8,Inverse variance weighted,29,0.97 [0.9-1.04],0.385576077950277,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PGA4,Pepsin A-4,Inverse variance weighted,7,0.85 [0.58-1.24],0.38984659552178,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.28 [0.73-2.27],0.390451705244553,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.15 [0.83-1.6],0.392059794731959,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSS,Cathepsin S,Inverse variance weighted,7,0.86 [0.6-1.22],0.392274674471983,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.68 [0.51-5.48],0.392940728750934,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MATN2,Matrilin-2,Inverse variance weighted,28,0.95 [0.85-1.07],0.399462312640848,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.95 [0.84-1.07],0.39962342503417,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.8 [0.48-1.34],0.401033236856267,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.33 [0.69-2.57],0.40130794990372,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,0.84 [0.56-1.26],0.40491952105936,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.13 [0.85-1.49],0.412901880593188,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,9,1.19 [0.79-1.78],0.413968637882416,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,0.48 [0.08-2.8],0.416431108973144,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MFGE8,Lactadherin,Inverse variance weighted,15,1.12 [0.85-1.49],0.420427219794596,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.03 [0.95-1.12],0.421919634600083,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCN5,CCN family member 5,Inverse variance weighted,12,0.93 [0.79-1.1],0.422655166467775,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.11 [0.85-1.45],0.425891143317631,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,1.13 [0.84-1.52],0.426320831305554,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,1.09 [0.88-1.34],0.426598614517527,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,0.91 [0.72-1.15],0.430587568935835,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.07 [0.9-1.28],0.432155676846901,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK10,Kallikrein-10,Wald ratio,1,0.6 [0.17-2.15],0.432464815912484,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.11 [0.86-1.43],0.433133585017589,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCG3,Secretogranin-3,Inverse variance weighted,16,0.9 [0.69-1.18],0.43371248489161,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.36 [0.63-2.92],0.434496647007144,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSH,Pro-cathepsin H,Inverse variance weighted,10,0.85 [0.55-1.29],0.437447105051957,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLGN,Calmegin,Inverse variance weighted,6,1.15 [0.81-1.63],0.440108873899307,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.78 [0.42-1.47],0.443083419712772,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PCDH1,Protocadherin-1,Inverse variance weighted,4,1.17 [0.79-1.72],0.443328203490708,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.21 [0.74-1.97],0.444063482809928,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.79 [0.43-1.44],0.444239711275538,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,0.92 [0.76-1.13],0.445158531061437,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,1.13 [0.82-1.56],0.445680506645494,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,0.7 [0.28-1.75],0.447317667105626,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FBLN2,Fibulin-2,Inverse variance weighted,6,0.84 [0.53-1.32],0.447739216809162,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.77 [0.39-1.52],0.449468277353518,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD70,CD70 antigen,Inverse variance weighted,11,0.92 [0.73-1.15],0.451307959303509,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.21 [0.74-1.97],0.452719270628441,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.11 [0.84-1.47],0.454078494215757,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ELN,Elastin,Inverse variance weighted,10,0.88 [0.64-1.22],0.454593409113176,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.57 [0.48-5.16],0.456190395942339,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.03 [0.95-1.11],0.459838056508354,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.95 [0.84-1.08],0.462975984313465,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.22 [0.72-2.05],0.463829199592241,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.94 [0.79-1.11],0.464184829359685,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CX3CL1,Fractalkine,Inverse variance weighted,12,1.16 [0.78-1.72],0.464731075972818,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,1.14 [0.81-1.61],0.465617933854298,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CFD,Complement factor D,Wald ratio,1,0.68 [0.25-1.9],0.466230645189131,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL6,Interleukin-6,Inverse variance weighted,6,1.08 [0.88-1.33],0.473293693440827,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1.15 [0.78-1.69],0.476052641513992,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.95 [0.83-1.09],0.479255044112723,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.97 [0.9-1.05],0.48097152621686,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.14 [0.79-1.66],0.482763804733913,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NRP1,Neuropilin-1,Inverse variance weighted,14,1.1 [0.84-1.44],0.483568012601877,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.09 [0.85-1.4],0.487804337292795,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PALM2,Paralemmin-2,Inverse variance weighted,9,1.07 [0.88-1.31],0.495030767527121,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.08 [0.87-1.33],0.499957472673929,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.06 [0.9-1.25],0.503385601653336,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.09 [0.85-1.39],0.504278840460877,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.41 [0.51-3.91],0.504586104940142,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.26 [0.64-2.48],0.506672863736352,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.83 [0.48-1.43],0.507804198409139,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DLK1,Protein delta homolog 1,Inverse variance weighted,10,1.12 [0.81-1.54],0.50971127024183,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.89 [0.64-1.25],0.509901149754423,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,0.67 [0.2-2.23],0.51297944961907,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LMNB2,Lamin-B2,Inverse variance weighted,8,0.88 [0.59-1.31],0.519140404571469,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,0.98 [0.91-1.05],0.521190545385762,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BOC,Brother of CDO,Inverse variance weighted,8,1.11 [0.81-1.52],0.52221839608502,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.16 [0.74-1.81],0.524960061641438,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PYY,Peptide YY,Inverse variance weighted,16,1.06 [0.89-1.25],0.527259601996249,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.28 [0.6-2.73],0.527955583115656,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.21 [0.67-2.17],0.528422735905334,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DSG3,Desmoglein-3,Inverse variance weighted,27,0.96 [0.84-1.09],0.529481519477396,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSD,Cathepsin D,Inverse variance weighted,7,0.85 [0.52-1.41],0.530491993720814,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.12 [0.79-1.59],0.531531089017859,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGALS4,Galectin-4,Inverse variance weighted,15,1.04 [0.92-1.19],0.533565137856527,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,1.03 [0.94-1.13],0.537018311665658,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,1.21 [0.66-2.19],0.538228146644898,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.95 [0.81-1.12],0.542125704049506,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRSS2,Trypsin-2,Inverse variance weighted,17,1.06 [0.87-1.3],0.545395635534442,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP6,Gastrotropin,Inverse variance weighted,4,0.79 [0.36-1.71],0.546165481090947,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRND,Prion-like protein doppel,Inverse variance weighted,15,1.1 [0.8-1.51],0.548558606450474,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.06 [0.87-1.29],0.550440718970977,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,1.1 [0.81-1.48],0.550924034989787,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,REN,Renin,Inverse variance weighted,8,0.9 [0.63-1.28],0.551621911480332,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,1.94 [0.22-17.43],0.55438399085604,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,1.12 [0.77-1.62],0.556777065600826,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL10,Interleukin-10,Inverse variance weighted,4,1.09 [0.81-1.48],0.55717513389522,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MMP7,Matrilysin,Wald ratio,1,0.88 [0.56-1.37],0.557464865237632,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.39 [0.46-4.2],0.560502519441177,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.73 [0.25-2.11],0.563078284773474,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.07 [0.86-1.32],0.566300259555633,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,31,1.05 [0.89-1.23],0.566952097507154,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.12 [0.77-1.62],0.567729804003026,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCN4,CCN family member 4,Inverse variance weighted,29,1.03 [0.93-1.15],0.570692265392323,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.12 [0.76-1.63],0.573796799644567,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RGMB,RGM domain family member B,Inverse variance weighted,5,0.83 [0.43-1.6],0.575071336063876,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.95 [0.78-1.15],0.579097852348081,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GAST,Gastrin,Inverse variance weighted,9,0.93 [0.71-1.21],0.582322212516541,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,1.29 [0.51-3.27],0.584437428242015,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,1.1 [0.78-1.56],0.588172603462933,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.1 [0.77-1.57],0.589317518396193,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.43 [0.39-5.3],0.593821730267534,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.08 [0.82-1.43],0.594854981093043,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.92 [0.68-1.24],0.597173446633312,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,0.91 [0.64-1.29],0.598538968955998,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.05 [0.87-1.27],0.598877454594131,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.06 [0.86-1.3],0.601694361425158,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.07 [0.83-1.38],0.604242970419934,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,1.33 [0.45-3.9],0.607937887428361,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPON2,Spondin-2,Inverse variance weighted,3,0.73 [0.22-2.44],0.611667972856051,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.16 [0.64-2.1],0.613689063467084,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.13 [0.7-1.82],0.616885098491329,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,17,0.97 [0.84-1.11],0.617330563541007,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,5,1.19 [0.6-2.36],0.617849233908462,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANG,Angiogenin,Inverse variance weighted,8,1.17 [0.64-2.14],0.618406863512815,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EGFLAM,Pikachurin,Wald ratio,1,1.49 [0.31-7.14],0.619004897921944,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.11 [0.74-1.64],0.619201238362622,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHGB,Secretogranin-1,Inverse variance weighted,7,1.13 [0.7-1.83],0.620019251254341,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,9,1.09 [0.78-1.53],0.623527635819695,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK4,Kallikrein-4,Inverse variance weighted,5,0.86 [0.47-1.58],0.629862040464603,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.92 [0.65-1.29],0.630983631330128,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.07 [0.82-1.39],0.634354547863833,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.04 [0.88-1.23],0.635770242360078,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.05 [0.85-1.29],0.636184655266273,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.87 [0.48-1.57],0.638516293884727,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.1 [0.73-1.66],0.640007244320093,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.95 [0.77-1.18],0.641486232289802,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL19,Interleukin-19,Inverse variance weighted,10,0.96 [0.81-1.14],0.642814603017371,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.11 [0.7-1.76],0.642869923058298,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.94 [0.73-1.21],0.644594760962915,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,0.98 [0.91-1.06],0.647126544207127,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH3,Cadherin-3,Inverse variance weighted,10,0.92 [0.64-1.32],0.650422832465201,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,XCL1,Lymphotactin,Inverse variance weighted,15,0.94 [0.7-1.25],0.650770752625049,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.06 [0.82-1.37],0.651050703238139,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.87 [0.47-1.61],0.651416199793476,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.03 [0.9-1.19],0.651485443979414,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ROBO4,Roundabout homolog 4,Inverse variance weighted,3,0.82 [0.33-2],0.656442917272166,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.89 [0.54-1.48],0.656510864369215,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.84 [0.39-1.82],0.657003080098294,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.9 [0.55-1.45],0.657998760360441,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.89 [0.53-1.49],0.658918832455906,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.98 [0.89-1.08],0.659402617281399,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.15 [0.61-2.19],0.659782594408501,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,1.02 [0.92-1.13],0.660775620846294,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,40,0.98 [0.9-1.07],0.661187046454746,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.12 [0.67-1.88],0.661530062980212,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.94 [0.69-1.27],0.666728045382251,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.95 [0.74-1.21],0.671175611146732,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.94 [0.69-1.27],0.678047058614621,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.07 [0.78-1.45],0.685411811301491,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.08 [0.75-1.55],0.686214891591489,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.07 [0.76-1.52],0.687940441610635,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,30,0.96 [0.81-1.15],0.688931041308648,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.16 [0.56-2.43],0.689268028464627,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.08 [0.74-1.57],0.690442809769714,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.93-1.11],0.69060534068254,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCN3,CCN family member 3,Inverse variance weighted,17,0.97 [0.84-1.12],0.690641816908176,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.8 [0.27-2.37],0.693232262330029,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.11 [0.66-1.87],0.696944144817726,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,POF1B,Protein POF1B,Inverse variance weighted,4,0.88 [0.45-1.71],0.705100544053998,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.85 [0.37-1.94],0.705383803054155,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.93 [0.63-1.37],0.706041007669057,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.88 [0.45-1.71],0.712145428470603,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.96 [0.76-1.21],0.71416944744228,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.02 [0.92-1.13],0.716611586963634,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD83,CD83 antigen,Inverse variance weighted,14,1.06 [0.78-1.42],0.72185074949051,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.37 [0.24-7.84],0.723978350129596,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.07 [0.75-1.52],0.724843191369744,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.88-1.2],0.725464052977237,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.95 [0.7-1.28],0.726628325043551,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.71 [0.11-4.73],0.727556061003818,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSL,Cathepsin L1,Inverse variance weighted,29,1.03 [0.88-1.21],0.730675535621375,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.87 [0.38-1.97],0.732592589300762,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.04 [0.84-1.28],0.734077582064259,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.19 [0.44-3.2],0.735829344009418,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,0.93 [0.63-1.39],0.736189202354872,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.92 [0.58-1.48],0.737421666677012,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.23 [0.36-4.19],0.738679920278952,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.93 [0.61-1.43],0.738926794018217,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.94 [0.63-1.39],0.740238726121753,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.04 [0.82-1.33],0.740415834605894,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.04 [0.83-1.31],0.741052333672405,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RETN,Resistin,Inverse variance weighted,19,0.95 [0.72-1.26],0.741152477559489,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.06 [0.74-1.54],0.742638145180893,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.08 [0.69-1.7],0.744588138854672,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.12 [0.57-2.19],0.746201983671161,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.91 [0.53-1.57],0.746757880138078,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.96 [0.77-1.21],0.746814781973628,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.95 [0.71-1.28],0.748589887398633,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.97 [0.81-1.16],0.748805183717067,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SDC1,Syndecan-1,Inverse variance weighted,12,1.04 [0.81-1.33],0.752224855445745,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.13 [0.53-2.42],0.755788953968122,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLAMF6,SLAM family member 6,Inverse variance weighted,2,1.13 [0.52-2.47],0.760334642193299,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.08 [0.64-1.83],0.763681177191275,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COLEC12,Collectin-12,Inverse variance weighted,3,1.13 [0.51-2.47],0.765878740728923,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.01 [0.94-1.09],0.770054541820455,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DRAXIN,Draxin,Inverse variance weighted,25,1.03 [0.86-1.23],0.770069253821336,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.89 [0.41-1.95],0.770160698758065,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.04 [0.81-1.33],0.770819284876931,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,1.12 [0.53-2.37],0.771493419055581,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.05 [0.76-1.45],0.773060795314849,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.95 [0.66-1.36],0.775244299404553,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.99 [0.89-1.09],0.776724435920262,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RSPO1,R-spondin-1,Inverse variance weighted,8,1.04 [0.79-1.37],0.777395103943432,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,0.98 [0.83-1.15],0.777629697716508,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.97 [0.78-1.2],0.777906298804875,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.92 [0.51-1.65],0.777942067195458,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRSS8,Prostasin,Inverse variance weighted,14,0.96 [0.72-1.27],0.781118439579461,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PGF,Placenta growth factor,Inverse variance weighted,5,0.95 [0.64-1.41],0.781554241778786,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.92 [0.5-1.69],0.788745323904818,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PSAP,Prosaposin,Inverse variance weighted,13,1.02 [0.87-1.2],0.790755567073725,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.97 [0.78-1.21],0.792672117449975,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.98 [0.83-1.16],0.792740225804353,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.97 [0.8-1.19],0.792972566198403,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.98 [0.85-1.13],0.793022350553615,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.03 [0.81-1.31],0.793523257264323,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.86 [0.28-2.67],0.795731399168281,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRTN3,Myeloblastin,Inverse variance weighted,20,1.03 [0.84-1.25],0.796616499559556,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.94 [0.57-1.53],0.796804380211164,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1.03 [0.82-1.29],0.799502274369236,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRELP,Prolargin,Inverse variance weighted,5,1.08 [0.58-2.04],0.80044608461184,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.93 [0.51-1.69],0.802547129903704,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PI3,Elafin,Inverse variance weighted,18,1.02 [0.85-1.23],0.804351837179326,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.03 [0.82-1.29],0.805823320987098,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.03 [0.84-1.26],0.808848054777688,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,1.05 [0.7-1.57],0.810271638360519,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AMBP,Protein AMBP,Inverse variance weighted,5,1.04 [0.77-1.39],0.813346813095578,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.86 [0.25-2.98],0.814295828651759,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,0.98 [0.82-1.17],0.816157864002981,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.86 [0.24-3.06],0.81616760776239,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.95 [0.61-1.48],0.818336062414973,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NECTIN4,Nectin-4,Inverse variance weighted,4,1.07 [0.58-2],0.819638164344246,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,1.07 [0.61-1.88],0.823272635966883,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.02 [0.85-1.22],0.82720476071031,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.11 [0.44-2.8],0.828819514438734,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CPA2,Carboxypeptidase A2,Inverse variance weighted,10,0.96 [0.68-1.37],0.831756211613408,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.96 [0.69-1.36],0.831771219674065,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.11 [0.4-3.1],0.835423579830209,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.05 [0.64-1.75],0.836080846769907,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.02 [0.88-1.18],0.836403976915725,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.99 [0.94-1.05],0.836961523055127,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.93 [0.48-1.8],0.837715224045492,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.05 [0.66-1.67],0.841630594377346,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CAPG,Macrophage-capping protein,Wald ratio,1,0.91 [0.37-2.25],0.842131191589952,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.06 [0.58-1.93],0.843733278926313,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.08 [0.5-2.32],0.845133547215216,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.02 [0.83-1.26],0.845960145774437,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,0.93 [0.43-1.98],0.846725703717496,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.07 [0.56-2.03],0.848567723899984,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,4,1.09 [0.43-2.78],0.8522739429942,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,0.98 [0.76-1.26],0.858520557896491,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.06 [0.56-2],0.860217975836206,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.9 [0.26-3.07],0.862473873588002,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHAD,Chondroadherin,Inverse variance weighted,15,0.99 [0.88-1.12],0.862788274045241,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,OCLN,Occludin,Inverse variance weighted,2,1.06 [0.53-2.14],0.863531493731157,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CTSB,Cathepsin B,Inverse variance weighted,28,1.01 [0.89-1.14],0.86421193674465,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PENK,Proenkephalin-A,Inverse variance weighted,15,0.98 [0.77-1.25],0.865291169080895,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,0.96 [0.64-1.46],0.866242003984203,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD302,CD302 antigen,Inverse variance weighted,11,0.98 [0.78-1.24],0.8731107935288,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.82 [0.08-8.82],0.873243525395141,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.97 [0.67-1.42],0.876121485315606,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.03 [0.72-1.46],0.87642841770457,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK11,Kallikrein-11,Inverse variance weighted,13,1.02 [0.76-1.39],0.876797747175747,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.98 [0.71-1.33],0.87768322401702,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.92 [0.32-2.69],0.88177861351556,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AFP,Alpha-fetoprotein,Inverse variance weighted,67,0.99 [0.89-1.11],0.881781988710668,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CHGA,Chromogranin-A,Inverse variance weighted,5,0.97 [0.68-1.4],0.888190560769952,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.9-1.1],0.888216432261447,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1.01 [0.92-1.1],0.889086080052729,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.94-1.06],0.893410859390822,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.02 [0.79-1.32],0.893684143706431,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.99 [0.88-1.11],0.898020154302335,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.98 [0.7-1.37],0.898377169441832,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,VWC2,Brorin,Inverse variance weighted,12,1.03 [0.69-1.52],0.900572326282338,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.98 [0.72-1.34],0.902238937257329,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL18,Interleukin-18,Inverse variance weighted,26,0.99 [0.84-1.16],0.902481244510168,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,1.01 [0.82-1.25],0.910498851962341,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.96 [0.52-1.81],0.911228882093137,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RSPO3,R-spondin-3,Inverse variance weighted,5,1.02 [0.67-1.56],0.912390850927846,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH17,Cadherin-17,Inverse variance weighted,31,1 [0.91-1.08],0.912604550855659,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.91 [0.17-4.8],0.915262430473978,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,1.06 [0.33-3.4],0.916082807830686,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SCGB1A1,Uteroglobin,Inverse variance weighted,38,1.01 [0.87-1.16],0.916635201509631,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,1.03 [0.57-1.86],0.918969605079082,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LCN15,Lipocalin-15,Inverse variance weighted,22,1 [0.92-1.1],0.921463898282389,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,0.99 [0.86-1.15],0.92240008990452,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.93 [0.22-3.89],0.92340867857791,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.96 [0.43-2.15],0.924553908807133,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.04 [0.47-2.31],0.925218670514982,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.01 [0.83-1.22],0.925360605242302,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.99 [0.84-1.17],0.925498323093159,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.03 [0.57-1.87],0.928466937666701,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,0.99 [0.87-1.14],0.929357954384638,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.01 [0.77-1.33],0.930051590799169,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,GCG,Pro-glucagon,Inverse variance weighted,2,1.06 [0.28-4.04],0.93178050705923,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.99 [0.76-1.29],0.932871099587766,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.96 [0.32-2.84],0.936982619300735,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,0.99 [0.71-1.37],0.938892039545733,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1 [0.92-1.09],0.941128824176211,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,0.98 [0.66-1.48],0.94120396558842,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD7,T-cell antigen CD7,Inverse variance weighted,12,1 [0.9-1.1],0.943118187892907,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD164,Sialomucin core protein 24,Inverse variance weighted,8,1.01 [0.77-1.33],0.944779588540356,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1 [0.9-1.12],0.947503038261355,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.98 [0.6-1.62],0.951024935276934,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,14,1 [0.9-1.12],0.952481703900711,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.99 [0.61-1.6],0.954169022319912,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.01 [0.8-1.26],0.954291934755901,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1 [0.87-1.14],0.955021203198566,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.01 [0.78-1.3],0.960742419402101,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD160,CD160 antigen,Inverse variance weighted,24,1 [0.83-1.22],0.961530138409994,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,KLK8,Kallikrein-8,Inverse variance weighted,5,1.01 [0.65-1.57],0.962712366225459,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,MSLN,Mesothelin,Inverse variance weighted,11,0.99 [0.7-1.4],0.964874119720749,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,SEPTIN8,Septin-8,Inverse variance weighted,4,1.02 [0.48-2.17],0.965873578890877,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CDH15,Cadherin-15,Inverse variance weighted,4,0.99 [0.54-1.79],0.966428515534636,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.04 [0.2-5.42],0.966966467693035,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1 [0.8-1.24],0.967332038559576,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1 [0.76-1.3],0.971333885375738,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,C7,Complement component C7,Inverse variance weighted,26,1 [0.9-1.1],0.971846451604728,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1 [0.86-1.15],0.973131203568642,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CD99,CD99 antigen,Inverse variance weighted,4,1.01 [0.58-1.74],0.974523700625093,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,AHNAK2,Protein AHNAK2,Inverse variance weighted,3,1.01 [0.51-2],0.9751117846971,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.99 [0.41-2.35],0.9755934936197,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1 [0.74-1.33],0.976867904608502,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PKD1,Polycystin-1,Inverse variance weighted,12,1 [0.73-1.36],0.977705174764231,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1 [0.93-1.07],0.978364245549529,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.99 [0.64-1.55],0.978651900428264,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.99 [0.58-1.7],0.979432189176231,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,1.01 [0.48-2.13],0.98071376516736,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.02 [0.17-6.16],0.982260218579897,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.01 [0.61-1.65],0.982412152107304,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CALB1,Calbindin,Inverse variance weighted,9,1 [0.66-1.52],0.984684164789536,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.99 [0.52-1.9],0.984895476028074,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.99 [0.47-2.09],0.985085459400671,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1 [0.75-1.32],0.988023771735486,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,LGALS9,Galectin-9,Inverse variance weighted,36,1 [0.9-1.11],0.989624866743614,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1 [0.63-1.58],0.994093842768045,trans
Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1 [0.85-1.18],0.997387697104068,trans
